Variables | rs2273267 (patients/controls) | Crude OR (95% CI) | P | Adjusted ORa (95% CI) | P a | |
---|---|---|---|---|---|---|
AA/AT | TT | |||||
Age, months | ||||||
 < 17 | 102/414 | 12/40 | 1.22 (0.62–2.41) | 0.571 | 1.23 (0.62–2.43) | 0.556 |
 ≥ 17 | 89/467 | 10/37 | 1.42 (0.68–2.96) | 0.351 | 1.42 (0.68–2.96) | 0.350 |
Gender | ||||||
 Female | 72/348 | 12/31 | 1.87 (0.92–3.82) | 0.085 | 1.84 (0.90–3.77) | 0.094 |
 Male | 119/533 | 10/46 | 0.97 (0.48–1.99) | 0.942 | 0.97 (0.47–1.97) | 0.925 |
Clinical stages | ||||||
 I + II | 84/881 | 13/77 | 1.77 (0.94–3.32) | 0.075 | 1.77 (0.94–3.32) | 0.075 |
 III + IV | 48/881 | 7/77 | 1.67 (0.73–3.81) | 0.225 | 1.66 (0.73–3.80) | 0.229 |